RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pfizer Inc.

A collection of news and information related to Pfizer Inc. published by this site and its partners.

Top Pfizer Inc. Articles

Displaying items 1-12
  • Md. man pleads guilty to selling fake Viagra on Craigslist

    A 34-year-old La Plata man pleaded guilty Friday to peddling phony Viagra on Craigslist, after the four-month scheme was discovered by an undercover investigator working for pharmaceutical giant Pfizer Corp. Dwayne Alan Skiles faces up to five years in...
  • FDA approves new drug for erectile dysfunction

    Men now have a new option to treat erectile dysfunction. The U.S. Food and Drug Administration has approved the new drug Stendra to treat the illness that causes problems in the sex lives of 30 million men. It is the first erectile dysfunction drug in a...
  • Viagra ads become more explicit

    More cringing and possibly more explanation is in store for parents watching TV with children when the latest Viagra commercials appear on screens. Euphemistic and delicate phrasing about erectile dysfunction by an unseen narrator? Done and gone. "So...
  • Vivus' Stendra gets FDA approval for use 15 minutes before sex

    (Reuters) - The erectile dysfunction drug Stendra, currently approved by the U.S. Food and Drug Administration for use 30 minutes before sex, has now been approved for use as little as 15 minutes before sex, the drug's developers said on Thursday....
  • Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

    (Reuters - Pfizer Inc and India's Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. U.S. District Judge Peter Sheridan...
  • Amgen seeks U.S. approval of new cholesterol-fighting drug

    (Reuters) - Amgen Inc said on Thursday it applied to U.S. health regulators to sell its cholesterol fighter, evolocumab, becoming the first company to seek approval of a medicine from a closely watched new class of potent heart drugs. Amgen is racing...
  • Pill look different? Shape and color changes may prompt lapses

    Pill look different? Shape and color changes may prompt lapses
    In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals - coupled with insurance companies' efforts to keep healthcare...
  • Walgreen considers headquarters move: Is tax loophole unpatriotic?

    Walgreen considers headquarters move: Is tax loophole unpatriotic?
    Walgreen Co. is at a crossroads, but it may not be "at the corner of happy and healthy" as its advertising slogan suggests. The nation's largest drugstore chain is considering a move that would allow it to significantly cut its tax bill and increase...
  • In A Yale Experiment, A Hairless Man Grows Hair

    In A Yale Experiment, A Hairless Man Grows Hair
    Kyle Rhodes visited Dr. Brett A. King at the Yale School of Medicine late last summer, seeking help for a severe case of psoriasis. The Killingworth man, now 25, also had — still has — alopecia, the condition that causes a person's hair to...
  • FDA says new cholesterol drugs may not need outcome studies

    FDA says new cholesterol drugs may not need outcome studies
    Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
  • Generic Viagra to be available in late 2017

    Generic Viagra will hit the market more than two years earlier than expected under a settlement reached by Teva Pharmaceutical Industries Ltd. and the maker of the impotence drug, Pfizer Inc. Teva can enter the market on Dec. 11, 2017, and will pay...
  • FDA bars medications made by Indian generics giant Ranbaxy

    FDA bars medications made by Indian generics giant Ranbaxy
    The Food & Drug Administration on Monday barred the import of any medications made at the premier manufacturing plant of one of the world's largest makers of generic medications, Ranbaxy Laboratories Ltd. The FDA cited Ranbaxy's failure to respond...